CollPlant Biotechnologies Ltd (CLGN)
5.30
+0.04
(+0.76%)
USD |
NASDAQ |
Apr 23, 16:00
5.30
0.00 (0.00%)
After-Hours: 20:00
CollPlant Biotechnologies Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0009 |
| June 30, 2020 | 0.0021 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0025 |
| December 31, 2019 | 0.0059 |
| September 30, 2019 | -3.985 |
| June 30, 2019 | 0.0197 |
| March 31, 2019 | 0.0129 |
| December 31, 2018 | 0.0081 |
| September 30, 2018 | 0.0141 |
| June 30, 2018 | 0.0162 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.392 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.985
Minimum
Sep 2019
0.0197
Maximum
Jun 2019
-0.2081
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Compugen Ltd | 0.00 |
| Pluri Inc | 5.547 |
| BioLine Rx Ltd | 0.7391 |
| Can Fite Biofarma Ltd | 0.00 |
| BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.13M |
| Total Liabilities (Quarterly) | 5.786M |
| Shareholders Equity (Quarterly) | 28.34M |
| Current Ratio | 8.620 |